Related references
Note: Only part of the references are listed.Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure
Gregg C. Fonarow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Parameters of ventricular contractility in mice: influence of load and sensitivity to changes in inotropic state
An Van den Bergh et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2008)
Phosphodiesterase type 5 - Expanding roles in cardiovascular regulation
David A. Kass et al.
CIRCULATION RESEARCH (2007)
Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility
Jayan Nagendran et al.
CIRCULATION (2007)
Phosphodiesterase regulation of nitric oxide signaling
David A. Kass et al.
CARDIOVASCULAR RESEARCH (2007)
Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches
Junya Takagawa et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Compartmentalization of cardiac β-adrenergic inotropy modulation by phosphodiesterase type 5
Eiki Takimoto et al.
CIRCULATION (2007)
cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system - A molecular toolbox for generating compartmentalized cAMP signaling
Miles D. Houslay et al.
CIRCULATION RESEARCH (2007)
Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart
Paul R. Forfia et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Overview of PDEs and their regulation
Kenji Omori et al.
CIRCULATION RESEARCH (2007)
Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure
Gregory D. Lewis et al.
CIRCULATION (2007)
Cardiovascular cGMP-generating systems in physiological and pathological conditions
M. C. Cerra et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Compartmentation of cyclic nucleotide signaling in the heart - The role of cyclic nucleotide phosphodiesterases
Rodolphe Fischmeister et al.
CIRCULATION RESEARCH (2006)
Compartmentalized phosphodiesterase-2 activity blunts β-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway
M Mongillo et al.
CIRCULATION RESEARCH (2006)
Sildenafil inhibits β-adrenergic-stimulated cardiac contractility in humans
BA Borlaug et al.
CIRCULATION (2005)
Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias
SE Lehnart et al.
CELL (2005)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism
E Takimoto et al.
CIRCULATION RESEARCH (2005)
Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases
M Mongillo et al.
CIRCULATION RESEARCH (2004)
Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction
S Janssens et al.
CIRCULATION RESEARCH (2004)
Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A
M Kuhn
CIRCULATION RESEARCH (2003)
Regulation of nitric oxide-sensitive guanylyl cyclase
A Friebe et al.
CIRCULATION RESEARCH (2003)
Ca2+ uptake by the sarcoplasmic reticulum in ventricular myocytes of the SERCA2b/b mouse is impaired at higher Ca2+ loads only
G Antoons et al.
CIRCULATION RESEARCH (2003)
Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells
SD Rybalkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases
J Tremblay et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Cardiac phosphodiesterase 5 (cGMP-specific) modulates β-adrenergic signaling in vivo and is down-regulated in heart failure
H Senzaki et al.
FASEB JOURNAL (2001)